Company Profile

Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Employees

295

Sector

Medical Equipment, Supplies & Distribution

More about the company

05/09/23	Conformis, Inc. Announces Board Changes	CI
05/09/23	Conformis, Inc.(NasdaqCM:CFMS) dropped from NASDAQ Composite Index	CI
04/09/23	Restor3D, Inc. completed the acquisition of Conformis, Inc. from shareholders.	CI
01/09/23	Conformis, Inc.(NasdaqCM:CFMS) dropped from S&P TMI Index	CI
02/08/23	Conformis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/08/23	Earnings Flash (CFMS) CONFORMIS Posts Q2 Revenue $13M	MT
23/06/23	Top Midday Gainers	MT
23/06/23	Global markets live: 3M Company, Meta, Moderna, Carmax, Shell...
23/06/23	It just won't go away
23/06/23	Wall Street Set to Open Lower Ahead of June's Flash PMI; Oil Prices Drop Sharply	MT
23/06/23	US Futures Trend Lower Premarket Friday Ahead of June's Flash PMI	MT
23/06/23	Top Premarket Gainers	MT
23/06/23	ConforMIS Agrees to be Acquired by restor3d	MT

09/05/23	Oppenheimer Downgrades ConforMIS to Perform From Outperform, Removes $6 Price Target	MT
11/11/22	Oppenheimer Adjusts ConforMIS Price Target to $8 From $1.25, Maintains Outperform Rating	MT

05/09/23	Restor3d Completes Acquisition of Conformis	AQ
05/09/23	Conformis : Termination of Material Agreement - Form 8-K	PU
23/08/23	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
21/08/23	Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
02/08/23	ConforMIS: Q2 Earnings Snapshot	AQ

23/06/23	USA-Les valeurs à suivre à Wall Street (actualisé)
17/03/23	Medacta: dividende maintenu, malgré le tassement du bénéfice en 2022
15/11/22	Bourse Zurich: les indices repartent à la hausse au lendemain d'un repli
15/11/22	Medacta: archivia vertenza sui brevetti negli Usa
15/11/22	Bourse Zurich: le SMI un peu plus ferme à l'approche de la mi-journée

Manager	Title	Age	Since
James Jacobus PSD	President	55	-
Kenneth Gall SEC	Corporate Secretary	-	-
Gregory Anglum TRE	Treasurer	56	-

Conformis, Inc. Share Price

Stocks

CFMS

US20717E2000

Medical Equipment, Supplies & Distribution

Latest news: Conformis, Inc.

Analysts' recommendations: Conformis, Inc.

Press Releases: Conformis, Inc.

News in other languages: Conformis, Inc.

Managers and Directors: Conformis, Inc.

Latest insider transactions

Medical Devices & Implants

Company Profile

Director	Title	Age	Since
Gregory Anglum BRD	Director/Board Member	56	04/07/2023
Kenneth Gall BRD	Director/Board Member	-	04/09/2023
James Jacobus BRD	Director/Board Member	55	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
05/09/23	Denise Pedulla	Issuer sale	General Counsel	18,000	0.2285%
05/09/23	Philip Johnston	Issuer sale	Director	19,273	0.2447%
05/09/23	Gary Fischetti	Issuer sale	Director	10,470	0.1329%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONFORMIS, INC.	-.--%	-.--%	-	-	17.8M
STRYKER CORPORATION	-0.34%	-2.72%	-27.24%	-3.61%	105B
SMITH & NEPHEW PLC	+0.27%	-0.19%	-23.27%	-0.29%	11.63B
GLAUKOS CORPORATION	-1.39%	-5.59%	+93.52%	+114.66%	9.52B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.88%	+6.11%	-49.75%	-66.69%	4.22B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.01%	+0.94%	-26.40%	+22.21%	2.39B
INSPIRE MEDICAL SYSTEMS, INC.	-1.38%	+1.88%	-5.21%	-60.40%	2.19B
INSIGHT LIFETECH CO., LTD.	+1.06%	+6.15%	-	-	1.96B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.56%	+3.35%	-18.85%	-27.25%	1.55B
Average	+0.74%	+1.24%	-8.17%	-3.05%	17.33B
Weighted average by Cap.	-0.14%	-2.19%	-18.72%	+2.24%